Point72 Asset Management L.P. Invests $112.36 Million in Immunovant, Inc. (NASDAQ:IMVT)

Point72 Asset Management L.P. bought a new position in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) during the fourth quarter, Holdings Channel reports. The fund bought 2,666,883 shares of the company’s stock, valued at approximately $112,356,000. Other institutional investors and hedge funds also recently modified their holdings of the company. Headlands Technologies LLC acquired […]

Related Keywords

Los Angeles ,California ,United States ,Eva Renee Barnett ,Peter Salzmann ,Corecap Advisors ,Immunovant Inc ,Securities Exchange Commission ,Jpmorgan Chase Co ,Goldman Sachs Group ,Jp Morgan Private Wealth Advisors ,Assetmark Inc ,Headlands Technologies ,Nasdaq ,Wolfe Research ,Holdings Channel ,Los Angeles Capital Management ,Free Report ,Angeles Capital Management ,Private Wealth Advisors ,Cap Advisors ,Renee Barnett ,Exchange Commission ,Trading Down ,Get Free Report ,Visit Holdingschannel ,Immunovant Daily ,